Miracle 1°C
Hyperthermia Machine
High Frequency Deep Heat Technology.
Engineered for Precision.
Built for Performance.
0.46 MHz
High Frequency Technology
Safe Therapy
Controlled thermal delivery
Precision
Real-time monitoring
Advanced System
Duplex Frequency


Product Overview
The Miracle 1°C is an advanced high frequency hyperthermia system designed for thermal therapy applications in oncology and allied medical disciplines.
Operating at 0.46 MHz, the system generates deep, controlled heat within targeted body tissue through a resistive duplex frequency transmission mechanism, delivering uniform thermal energy to both subcutaneous and deep tissue layers.
Deep Heat
Generates controlled thermal energy deep within targeted tissue.
0.46 MHz
Operates using high-frequency resistive duplex technology.
Targeted Therapy
Designed for precision treatment across multiple anatomical sites.
Reliable Performance
Engineered for safe, consistent, and dependable operation.
Technical Specifications
Designed with precision engineering and advanced thermal control technology.
Note: Final technical specifications should be verified and approved by the technical team before publication.
Operating Frequency
0.46 MHz
Transmission Mode
Resistive Duplex Frequency
Session Duration
60–120 Minutes
Treatment Frequency
2–5 Sessions / Week
Target Temperature
40–43°C (Tissue Level)
Applicator
Interchangeable
Control System
Advanced Real-Time Temperature Management
0.46 MHz
High Frequency Operation
40–43°C
Target Tissue Temperature
60–120 Min
Typical Session Duration
Technology Features
Miracle 1°C combines precision engineering with advanced hyperthermia technology to deliver controlled thermal energy efficiently while maintaining consistent treatment performance.
Resistive Deep Heat
Delivers thermal energy uniformly into deeper tissue layers.
Duplex Frequency
Dual-mode energy transmission for broader anatomical coverage.
Temperature Monitoring
Real-time monitoring helps maintain controlled thermal delivery.
No Nerve Stimulation
High-frequency energy minimizes stimulation of sensory and motor nerves.
Interchangeable Applicators
Adaptable applicators for different anatomical treatment areas.

Safety Features
Multiple layers of protection designed to support reliable and controlled operation.
Automatic Cut-Off
Automatically stops energy delivery when threshold temperatures are reached.
Continuous Monitoring
Real-time electrode-level temperature monitoring throughout treatment.
Non-Invasive
No radiation, chemicals, or invasive procedures involved.
Skin Protection
Designed to reduce the risk of erythema and surface tissue damage.
International Standards
Designed to support internationally recognized manufacturing standards.
Designed with Safety in Mind
Every Miracle 1°C system incorporates multiple safety mechanisms, continuous monitoring, and engineering controls to support reliable operation during clinical use.


Operating Principle
Miracle 1°C generates controlled heat within targeted tissue using high-frequency electrical energy. Instead of heating externally, thermal energy develops within the tissue through molecular movement, creating a precise and measurable rise in temperature.
As tissue temperature increases, local circulation improves and normal physiological responses become more active, while the skin surface remains protected.
High Frequency Energy
Electrical energy is delivered through high-frequency resistive technology.
Controlled Heat
Heat is generated uniformly within targeted tissue layers.
Improved Circulation
Controlled thermal elevation supports improved local blood circulation.
Cellular Response
Thermal energy promotes measurable physiological activity in the treatment area.
Clinical Applications
Designed to support healthcare professionals within established clinical treatment pathways.
Miracle 1°C is designed to complement established oncology treatment approaches. It has been applied in combination with radiotherapy, chemotherapy, and immunotherapy protocols under the direction of treating physicians.
The system is intended to support existing clinical workflows and is not designed to replace standard treatment protocols.
Supports Oncology Care
Designed to complement established oncology treatment workflows.
Physician Directed
Treatment protocols are determined by qualified healthcare professionals.
Combination Therapy
May be used alongside radiotherapy, chemotherapy, and immunotherapy as clinically appropriate.
Clinical Workflow
Designed to integrate into existing treatment environments.

Product Documents
Download brochures, technical specifications, and user documentation.
Product Brochure
Complete overview of Miracle 1°C technology, applications, and benefits.